MCLOVIN'S PET – Trademark Portfolio
Entity Type: 03
MCLOVIN'S PET holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 6 filings in this category. The portfolio also extends into Class 21 (Housewares) across 5 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include MCLOVINS, MCLOVIN S, MCLOVIN'S, RX POCKETS, and RX CAPSULES. The owner is based in CHINO, CA.
4401 EUCALYPTUS AVE, STE 100
CHINO, CA 91710
Showing of trademarks Trademarks
Trademark Classifications
MCLOVIN'S PET's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does MCLOVIN'S PET have?
MCLOVIN'S PET has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does MCLOVIN'S PET file in?
MCLOVIN'S PET files trademarks across 5 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 21 (Housewares), Class 18 (Leather Goods), Class 28 (Toys & Sporting Goods), Class 20 (Furniture). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are MCLOVIN'S PET's most well-known trademarks?
MCLOVIN'S PET's registered trademark portfolio includes well-known marks such as MCLOVINS, MCLOVIN S, MCLOVIN'S, RX POCKETS, and RX CAPSULES. These are among 6 currently registered trademarks in the portfolio.
What is MCLOVIN'S PET's trademark registration success rate?
MCLOVIN'S PET has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.